Physician profile
John Duffy
NPI 1568519437
$8,290.24
in general payments reported to CMS, 2019-2025
48 companies · $1,353 in 2025
The $1,353 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,186 · 2020: $824 · 2021: $1,343 · 2022: $983 · 2023: $1,090 · 2024: $1,511 · 2025: $1,353.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,954.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,954.17 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $831.57 | 2019-2025 | Botox, Lupron Depot |
| Astellas Pharma US INC | $744.44 | 2019-2025 | Xtandi, Veozah |
| Boston Scientific Corporation | $659.73 | 2019-2025 | Axonics, Spaceoar Vue System - 10ml, Solyx Sis System |
| Sumitomo Pharma America, INC. | $506.32 | 2023-2025 | Gemtesa, Orgovyx |
| Coloplast Corp | $466.49 | 2019-2025 | |
| Endo Pharmaceuticals INC. | $424.29 | 2019-2024 | Xiaflex, Aveed |
| Antares Pharma, INC. | $370.63 | 2020-2025 | Xyosted, Nocdurna, Tlando |
| Allergan, INC. | $358.91 | 2019-2021 | |
| Myriad Genetic Laboratories, INC. | $345.06 | 2020-2025 | Prolaris |
| Janssen Biotech, INC. | $301.00 | 2019-2025 | Erleada, Akeega |
| Bayer Healthcare Pharmaceuticals INC. | $296.54 | 2019-2025 | |
| Pfizer INC. | $278.01 | 2019-2025 | |
| Procept Biorobotics Corporation | $249.99 | 2023-2025 | Aquabeam Robotic System |
| Dendreon Pharmaceuticals LLC | $206.68 | 2019-2022 | |
| Axonics, INC. | $145.69 | 2020-2023 | Axonics, Bulkamid |
Show all 48 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Duffy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.